يعرض 1 - 10 نتائج من 91 نتيجة بحث عن '"BROMOCRIPTINE"', وقت الاستعلام: 1.42s تنقيح النتائج
  1. 1
    مورد إلكتروني

    مصطلحات الفهرس: animal tissue, article, cell size, controlled study, corpus striatum, drug effect, long term care, male, mouse, nerve ending, nonhuman, priority journal, rat, sprouting, substantia nigra, animal experiment, 2 ethoxy 1(2h) quinolinecarboxylic acid ethyl ester/pd [Pharmacology], 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine/ip [Intraperitoneal Drug Administration], 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine/pd [Pharmacology], 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate/ip [Intraperitoneal Drug Administration], 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate/pd [Pharmacology], benserazide plus levodopa/po [Oral Drug Administration], benserazide plus levodopa/pd [Pharmacology], bromocriptine/ip [Intraperitoneal Drug Administration], bromocriptine/pd [Pharmacology], cocaine/ip [Intraperitoneal Drug Administration], cocaine/pd [Pharmacology], cocaine/sc [Subcutaneous Drug Administration], dopamine 2 receptor blocking agent/pd [Pharmacology], dopamine 2 receptor stimulating agent/pd [Pharmacology], dopamine receptor blocking agent/po [Oral Drug Administration], dopamine receptor blocking agent/pd [Pharmacology], dopamine receptor stimulating agent/ip [Intraperitoneal Drug Administration], dopamine receptor stimulating agent/pd [Pharmacology], dopamine receptor stimulating agent/sc [Subcutaneous Drug Administration], haloperidol/po [Oral Drug Administration], haloperidol/pd [Pharmacology], sulpiride/ip [Intraperitoneal Drug Administration], sulpiride/pd [Pharmacology], 2 ethoxy 1(2h) quinolinecarboxylic acid ethyl ester/ip [Intraperitoneal Drug Administration], Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33106Test
    Click here for full text options
    LibKey Link

  2. 2
    مورد إلكتروني

    مصطلحات الفهرس: extrapyramidal symptom/si [Side Effect], hallucination/si [Side Effect], human, hypomania/si [Side Effect], liver dysfunction/si [Side Effect], nausea/si [Side Effect], orthostatic hypotension/dt [Drug Therapy], orthostatic hypotension/si [Side Effect], Parkinson disease/di [Diagnosis], Parkinson disease/dt [Drug Therapy], Parkinson disease/et [Etiology], psychosis/dt [Drug Therapy], psychosis/si [Side Effect], rash/si [Side Effect], review, sedation, amantadine/ae [Adverse Drug Reaction], amantadine/dt [Drug Therapy], bromocriptine/ae [Adverse Drug Reaction], bromocriptine/do [Drug Dose], bromocriptine/dt [Drug Therapy], cabergoline/ae [Adverse Drug Reaction], cabergoline/do [Drug Dose], cabergoline/dt [Drug Therapy], cabergoline/pk [Pharmacokinetics], catechol methyltransferase inhibitor/ae [Adverse Drug Reaction], catechol methyltransferase inhibitor/dt [Drug Therapy], chlorpromazine/ae [Adverse Drug Reaction], chlorpromazine/dt [Drug Therapy], decarboxylase inhibitor/ae [Adverse Drug Reaction], decarboxylase inhibitor/dt [Drug Therapy], entacapone/ae [Adverse Drug Reaction], entacapone/dt [Drug Therapy], ephedrine/dt [Drug Therapy], levodopa/ae [Adverse Drug Reaction], levodopa/do [Drug Dose], levodopa/dt [Drug Therapy], midodrine/dt [Drug Therapy], olanzapine/ae [Adverse Drug Reaction], olanzapine/dt [Drug Therapy], pergolide/ae [Adverse Drug Reaction], pergolide/do [Drug Dose], pergolide/dt [Drug Therapy], pimozide/ae [Adverse Drug Reaction], pimozide/dt [Drug Therapy], quetiapine/ae [Adverse Drug Reaction], quetiapine/dt [Drug Therapy], risperidone/dt [Drug Therapy], thioridazine/ae [Adverse Drug Reaction], thioridazine/dt [Drug Therapy], risperidone/ae [Adverse Drug Reaction], anxiety disorder/si [Side Effect], cardiovascular disease/si [Side Effect], clinical feature, confusion/si [Side Effect], disease course, disease exacerbation/si [Side Effect], drug bioavailability, drug choice, drug efficacy, drug half life, drug safety, dyskinesia/dt [Drug Therapy], dyskinesia/si [Side Effect], Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32509Test
    Click here for full text options
    LibKey Link

  3. 3
    مورد إلكتروني

    مصطلحات الفهرس: vertigo/si [Side Effect], visual disorder/si [Side Effect], vomiting/si [Side Effect], xerostomia/si [Side Effect], adamantane derivative/dt [Drug Therapy], amantadine/ae [Adverse Drug Reaction], amantadine/dt [Drug Therapy], apomorphine/ae [Adverse Drug Reaction], apomorphine/dt [Drug Therapy], benserazide plus levodopa/ae [Adverse Drug Reaction], benserazide plus levodopa/dt [Drug Therapy], benzatropine mesilate/ae [Adverse Drug Reaction], benzatropine mesilate/dt [Drug Therapy], biperiden/ae [Adverse Drug Reaction], biperiden/dt [Drug Therapy], bromocriptine/ae [Adverse Drug Reaction], bromocriptine/dt [Drug Therapy], bromocriptine mesilate/ae [Adverse Drug Reaction], bromocriptine mesilate/dt [Drug Therapy], cabergoline/ae [Adverse Drug Reaction], cabergoline/dt [Drug Therapy], carbidopa plus levodopa/ae [Adverse Drug Reaction], carbidopa plus levodopa/dt [Drug Therapy], cholinergic receptor blocking agent/dt [Drug Therapy], dopamine/cb [Drug Combination], dopamine/dt [Drug Therapy], dopamine receptor stimulating agent/dt [Drug Therapy], levodopa/dt [Drug Therapy], lisuride/ae [Adverse Drug Reaction], lisuride/dt [Drug Therapy], mesylic acid/ae [Adverse Drug Reaction], mesylic acid/dt [Drug Therapy], monoamine oxidase B inhibitor/dt [Drug Therapy], orphenadrine/ae [Adverse Drug Reaction], orphenadrine/dt [Drug Therapy], pergolide/ae [Adverse Drug Reaction], pergolide/dt [Drug Therapy], procyclidine/ae [Adverse Drug Reaction], procyclidine/dt [Drug Therapy], selegiline/ae [Adverse Drug Reaction], selegiline/dt [Drug Therapy], trihexyphenidyl/ae [Adverse Drug Reaction], trihexyphenidyl/dt [Drug Therapy], physical capacity, ankle edema/si [Side Effect], article, cognitive defect/si [Side Effect], confusion/si [Side Effect], drug monitoring, hallucination/si [Side Effect], human, motor dysfunction, motor performance, nausea/si [Side Effect], orthostatic hypotension/si [Side Effect], paranoia/si [Side Effect], Parkinson disease/dt [Drug Therapy], pathophysiology, physiotherapist, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33767Test
    Click here for full text options
    LibKey Link

  4. 4
    مورد إلكتروني

    مصطلحات الفهرس: animal tissue, article, cell size, controlled study, corpus striatum, drug effect, long term care, male, mouse, nerve ending, nonhuman, priority journal, rat, sprouting, substantia nigra, animal experiment, 2 ethoxy 1(2h) quinolinecarboxylic acid ethyl ester/pd [Pharmacology], 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine/ip [Intraperitoneal Drug Administration], 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine/pd [Pharmacology], 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate/ip [Intraperitoneal Drug Administration], 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate/pd [Pharmacology], benserazide plus levodopa/po [Oral Drug Administration], benserazide plus levodopa/pd [Pharmacology], bromocriptine/ip [Intraperitoneal Drug Administration], bromocriptine/pd [Pharmacology], cocaine/ip [Intraperitoneal Drug Administration], cocaine/pd [Pharmacology], cocaine/sc [Subcutaneous Drug Administration], dopamine 2 receptor blocking agent/pd [Pharmacology], dopamine 2 receptor stimulating agent/pd [Pharmacology], dopamine receptor blocking agent/po [Oral Drug Administration], dopamine receptor blocking agent/pd [Pharmacology], dopamine receptor stimulating agent/ip [Intraperitoneal Drug Administration], dopamine receptor stimulating agent/pd [Pharmacology], dopamine receptor stimulating agent/sc [Subcutaneous Drug Administration], haloperidol/po [Oral Drug Administration], haloperidol/pd [Pharmacology], sulpiride/ip [Intraperitoneal Drug Administration], sulpiride/pd [Pharmacology], 2 ethoxy 1(2h) quinolinecarboxylic acid ethyl ester/ip [Intraperitoneal Drug Administration], Article

  5. 5
    مورد إلكتروني

    مصطلحات الفهرس: extrapyramidal symptom/si [Side Effect], hallucination/si [Side Effect], human, hypomania/si [Side Effect], liver dysfunction/si [Side Effect], nausea/si [Side Effect], orthostatic hypotension/dt [Drug Therapy], orthostatic hypotension/si [Side Effect], Parkinson disease/di [Diagnosis], Parkinson disease/dt [Drug Therapy], Parkinson disease/et [Etiology], psychosis/dt [Drug Therapy], psychosis/si [Side Effect], rash/si [Side Effect], review, sedation, amantadine/ae [Adverse Drug Reaction], amantadine/dt [Drug Therapy], bromocriptine/ae [Adverse Drug Reaction], bromocriptine/do [Drug Dose], bromocriptine/dt [Drug Therapy], cabergoline/ae [Adverse Drug Reaction], cabergoline/do [Drug Dose], cabergoline/dt [Drug Therapy], cabergoline/pk [Pharmacokinetics], catechol methyltransferase inhibitor/ae [Adverse Drug Reaction], catechol methyltransferase inhibitor/dt [Drug Therapy], chlorpromazine/ae [Adverse Drug Reaction], chlorpromazine/dt [Drug Therapy], decarboxylase inhibitor/ae [Adverse Drug Reaction], decarboxylase inhibitor/dt [Drug Therapy], entacapone/ae [Adverse Drug Reaction], entacapone/dt [Drug Therapy], ephedrine/dt [Drug Therapy], levodopa/ae [Adverse Drug Reaction], levodopa/do [Drug Dose], levodopa/dt [Drug Therapy], midodrine/dt [Drug Therapy], olanzapine/ae [Adverse Drug Reaction], olanzapine/dt [Drug Therapy], pergolide/ae [Adverse Drug Reaction], pergolide/do [Drug Dose], pergolide/dt [Drug Therapy], pimozide/ae [Adverse Drug Reaction], pimozide/dt [Drug Therapy], quetiapine/ae [Adverse Drug Reaction], quetiapine/dt [Drug Therapy], risperidone/dt [Drug Therapy], thioridazine/ae [Adverse Drug Reaction], thioridazine/dt [Drug Therapy], risperidone/ae [Adverse Drug Reaction], anxiety disorder/si [Side Effect], cardiovascular disease/si [Side Effect], clinical feature, confusion/si [Side Effect], disease course, disease exacerbation/si [Side Effect], drug bioavailability, drug choice, drug efficacy, drug half life, drug safety, dyskinesia/dt [Drug Therapy], dyskinesia/si [Side Effect], Review

  6. 6
    مورد إلكتروني

    مصطلحات الفهرس: vertigo/si [Side Effect], visual disorder/si [Side Effect], vomiting/si [Side Effect], xerostomia/si [Side Effect], adamantane derivative/dt [Drug Therapy], amantadine/ae [Adverse Drug Reaction], amantadine/dt [Drug Therapy], apomorphine/ae [Adverse Drug Reaction], apomorphine/dt [Drug Therapy], benserazide plus levodopa/ae [Adverse Drug Reaction], benserazide plus levodopa/dt [Drug Therapy], benzatropine mesilate/ae [Adverse Drug Reaction], benzatropine mesilate/dt [Drug Therapy], biperiden/ae [Adverse Drug Reaction], biperiden/dt [Drug Therapy], bromocriptine/ae [Adverse Drug Reaction], bromocriptine/dt [Drug Therapy], bromocriptine mesilate/ae [Adverse Drug Reaction], bromocriptine mesilate/dt [Drug Therapy], cabergoline/ae [Adverse Drug Reaction], cabergoline/dt [Drug Therapy], carbidopa plus levodopa/ae [Adverse Drug Reaction], carbidopa plus levodopa/dt [Drug Therapy], cholinergic receptor blocking agent/dt [Drug Therapy], dopamine/cb [Drug Combination], dopamine/dt [Drug Therapy], dopamine receptor stimulating agent/dt [Drug Therapy], levodopa/dt [Drug Therapy], lisuride/ae [Adverse Drug Reaction], lisuride/dt [Drug Therapy], mesylic acid/ae [Adverse Drug Reaction], mesylic acid/dt [Drug Therapy], monoamine oxidase B inhibitor/dt [Drug Therapy], orphenadrine/ae [Adverse Drug Reaction], orphenadrine/dt [Drug Therapy], pergolide/ae [Adverse Drug Reaction], pergolide/dt [Drug Therapy], procyclidine/ae [Adverse Drug Reaction], procyclidine/dt [Drug Therapy], selegiline/ae [Adverse Drug Reaction], selegiline/dt [Drug Therapy], trihexyphenidyl/ae [Adverse Drug Reaction], trihexyphenidyl/dt [Drug Therapy], physical capacity, ankle edema/si [Side Effect], article, cognitive defect/si [Side Effect], confusion/si [Side Effect], drug monitoring, hallucination/si [Side Effect], human, motor dysfunction, motor performance, nausea/si [Side Effect], orthostatic hypotension/si [Side Effect], paranoia/si [Side Effect], Parkinson disease/dt [Drug Therapy], pathophysiology, physiotherapist, Article

  7. 7
    مورد إلكتروني
  8. 8
    مورد إلكتروني

    المصدر: Jawad , K , Koziarz , A , Dieterlen , M-T , Garbade , J , Etz , C D , Saeed , D , Langer , E , Stepan , H , Scholz , U , Krause , M , Brenner , P , Schulz , U , Borger , M A & Eifert , S 2022 , ' Long-Term Follow-Up of Mechanical Circulatory Support in Peripartum Cardiomyopathy (PPCM) Refractory to Medical Management : A Multicenter Study ' , Life , vol. 12 , no. 1 , 87 .

  9. 9
    مورد إلكتروني
  10. 10
    مورد إلكتروني

    المصدر: Jawad , K , Koziarz , A , Dieterlen , M-T , Garbade , J , Etz , C D , Saeed , D , Langer , E , Stepan , H , Scholz , U , Krause , M , Brenner , P , Schulz , U , Borger , M A & Eifert , S 2022 , ' Long-Term Follow-Up of Mechanical Circulatory Support in Peripartum Cardiomyopathy (PPCM) Refractory to Medical Management : A Multicenter Study ' , Life , vol. 12 , no. 1 , 87 .